Rockefeller Capital Management L.P. Relay Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	BUY	$14.16 - $24.02 $3,936 - $6,677	278 New	278 $4,000
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $13 - $34	1 New	1 $0
Q2 2021 Aug 10, 2021	SELL	$27.5 - $38.19 $59,565 - $82,719	-2,166 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$32.52 - $61.53 $70,438 - $133,273	2,166 New	2,166 $74,000

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $535M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.